A new explainer from Walk-In Clinic traces the specific patent timeline that made Canada the first G7 country to authorize generic semaglutide, pointing to a 2020 patent lapse, a January 4, 2026 data exclusivity end, and a March 2026 formulation patent expiry
Other times, it means returning to the medication regimens that were part of their daily lives before hospitalization
Overall, the latest human data on GLP-1 drugs and thyroid cancer risk have not demonstrated a clear causal link between GLP-1 therapy and increased medullary thyroid carcinoma rates
1 2 3 al
Unlike the injections which can be taken at anytime of day, it is best to administer the drops about thirty minutes before your first meal of the day
To put that into perspective, Ozempic and Wegovy are GLP-1 receptor agonists, while Zepbound and Mounjaro are dual GIP/GLP-1 receptor agonists